Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Current treatments for alopecia show no significant long-term benefits.

New alopecia treatments aim for better results and fewer side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Apremilast shows promise for several skin conditions but needs more research.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Using iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles increases drug release but reduces its targeting to hair follicles.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.